Background: Numerical rating scales (NRS), and verbal rating scales (VRS) showed to be reliable and valid tools for subjective cancer pain measurement, but no one of them consistently proved to be ...

Tris Pharma has reported positive outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol to treat moderate-to-severe ...

Cebranopadol is an investigational dual-nociceptin/orphanin FQ peptide receptor and µ-opioid peptide receptor agonist.

Further endpoints included improvements in back pain (Numeric Rating Scale [NRS] scores), spinal stiffness, functional ...

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

In the high-dose arm, the maximum pain was mild, indicated by less than 4.0 points on the numeric rating scale (NRS). In contrast, the maximum pain was reported to be severe (> 7.0 NRS ...

We assigned numeric codes to each level of each state ... [32] We examined interrater agreement on the NRS rating, a continuous variable, with intraclass correlation coefficients generated in ...